USA Expert Session | Exploring Opportunities and Navigating Change for Dutch LSH Entrepreneurs

The United States presents significant opportunities for research, innovation, and expansion for Dutch Life Sciences and Health (LSH) companies. Collaboration between the Netherlands and the United States in LSH brings unmatched value, leveraging complementary strengths to drive innovation. The recent transition to a new Trump administration may bring policy shifts and reshape the business landscape. Join us for the USA Expert Session to receive valuable insights into these emerging challenges and opportunities.

Why
The United States has the largest healthcare expenditure globally and offers a robust investment landscape for innovative medical technologies. The combination of market size, growth potential, and investment readiness makes the United States an attractive destination for Dutch LSH organizations seeking research, innovation, and collaboration opportunities.

Through the SMM LSH USA programme, coordinated by the Netherlands Enterprise Agency (RVO) and Task Force Health Care (TFHC), you can learn about key developments, establish sustainable (research) collaborations, and strengthen your position on the United States healthcare market.

In the upcoming USA Expert Session, we will reflect on the recent transition to the new Trump administration, the related policy shifts, and implications this may have on Dutch LSH companies who are (interested in) doing business with the United States.

Are you a Dutch Life Sciences & Health (LSH) organization, whether you’re just beginning to explore expansion opportunities or already well-established in the United States market? Join us to strengthen your U.S. strategy, build sustainable collaborations, and navigate the evolving U.S. healthcare market with confidence.

REGISTER HERE

What to expect?
The key objective of this expert session is to share business insights to support Dutch LSH entrepreneurs in navigating and adapting to the changing U.S. policy landscape.

• Gain perspectives from leading policy and legal experts
• Connect with specialists who provide essential support in doing business in the United States
• Learn from a real-world cases of a Dutch companies operating in the United States

When: 7 May 2025, 14:00 – 17:30 (doors open from 13:30)
Where: RVO Den Haag, Prinses Beatrixlaan 2, 2595 AL Den Haag
For: Dutch Life Sciences & Health Organizations active in Digital Health, Health Tech, MedTech, Telemedicine, and Medical Devices
Organizers: European American Chamber of Commerce Netherlands (EACC NL), Netherlands Enterprise Agency (RVO), Task Force Health Care

Agenda:
13:30 – 14:00: Walk-in

14:00 – 14:15: Welcome & Introduction of the SMM LSH USA Programme:

14:15 – 14:45: Policy & Regulatory

• Policy: Gain perspectives on U.S. policy shifts affecting Dutch LSH companies active on the U.S. market
• Regulatory: Exploring the FDA approval process

14:45 – 15:45: Business Expansion

• Specialists share key insights on challenges and solutions of doing business in the U.S. regarding back office, risk, tax, finance, insurance, talent, culture, site selection, and expansion

15:45 – 16:25: Experiences from LSH entrepreneurs

• Introduction to the legal side of doing business in the U.S.
• Moderated panel with Dutch LSH entrepreneurs on their experiences and lessons learned on expanding into the U.S. market

16:25 – 16:30: Closing

16:30 – 17:30: Networking drinks

Participation fee: Attending this Expert Session is free of charge. If you are unavailable to attend the event, please unregister at least a day ahead of the event.

REGISTER HERE